WO2008131329A1 - Différentiel d'énergie de surface de moule à lentille ophtalmique - Google Patents

Différentiel d'énergie de surface de moule à lentille ophtalmique Download PDF

Info

Publication number
WO2008131329A1
WO2008131329A1 PCT/US2008/061004 US2008061004W WO2008131329A1 WO 2008131329 A1 WO2008131329 A1 WO 2008131329A1 US 2008061004 W US2008061004 W US 2008061004W WO 2008131329 A1 WO2008131329 A1 WO 2008131329A1
Authority
WO
WIPO (PCT)
Prior art keywords
mold
lens
mold part
thermal plastic
surface energy
Prior art date
Application number
PCT/US2008/061004
Other languages
English (en)
Inventor
Changhong Yin
Scott F. Ansell
Original Assignee
Johnson & Johnson Vision Care, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/753,198 external-priority patent/US20080290534A1/en
Application filed by Johnson & Johnson Vision Care, Inc. filed Critical Johnson & Johnson Vision Care, Inc.
Priority to AU2008242679A priority Critical patent/AU2008242679A1/en
Priority to BRPI0810237-6A2A priority patent/BRPI0810237A2/pt
Priority to EP08746429A priority patent/EP2152503A1/fr
Priority to CA002684870A priority patent/CA2684870A1/fr
Priority to JP2010504307A priority patent/JP2010524729A/ja
Publication of WO2008131329A1 publication Critical patent/WO2008131329A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00—Producing optical elements, e.g. lenses or prisms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00—Producing optical elements, e.g. lenses or prisms
    • B29D11/00009—Production of simple or compound lenses
    • B29D11/00038—Production of contact lenses
    • B29D11/00125—Auxiliary operations, e.g. removing oxygen from the mould, conveying moulds from a storage to the production line in an inert atmosphere
    • B29D11/00192—Demoulding, e.g. separating lenses from mould halves
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/38—Moulds or cores; Details thereof or accessories therefor characterised by the material or the manufacturing process

Definitions

  • This invention describes molds and ophthalmic lenses formed with the molds and a surface energy differential therebetween.
  • contact lenses can be used to improve vision.
  • Various contact lenses have been commercially produced for many years. Early designs of contact lenses were fashioned from hard materials. Although these lenses are still currently used in some applications, they are not suitable for all patients due to their poor comfort and relatively low permeability to oxygen. Later developments in the field gave rise to soft contact lenses based upon hydrogels.
  • Hydrogel contact lenses are popular and often more comfortable to wear than contact lenses made of hard materials.
  • Malleable soft contact lenses made from hydrogels can be manufactured by forming a lens in a multi-part mold where the combined parts form a topography consistent with the desired final lens.
  • Ophthalmic lenses are often made by cast molding, in which a monomer material is deposited in a cavity defined between optical surfaces of opposing mold parts.
  • Multi-part molds used to fashion hydrogels into a useful article, such as an ophthalmic lens can include for example, a first mold part with a convex portion that corresponds with a back curve of an ophthalmic lens and a second mold part with a concave portion that corresponds with a front curve of the ophthalmic lens.
  • an uncured hydrogel lens formulation is placed between a front curve mold part and a back curve mold part. The mold parts are brought together to shape the lens formulation according to desired lens parameters.
  • a lens edge was formed about the perimeter of the formed lens by compression of an edge formed into the mold parts which penetrates the lens formulation and incises it into a lens portion and an excess ring portion.
  • the lens formulation was subsequently cured, for example by exposure to heat and light, thereby forming a lens.
  • mold portions are separated and the lens remains adhered to one of the mold portions.
  • the lens and the excess polymer ring must be separated and the excess polymer ring discarded.
  • lens damage may occur. Damage can include, for example: edge chips and tears; holes; lens delamination or pulls; lenses adhering to a wrong mold part, optical distortion; and surface marks.
  • the present invention includes improved molds and processes useful in the creation of an ophthalmic lens.
  • a mold material can be used with one or more additives which reduce the surface tension of the mold material and increase a differential between one or both mold parts and the lens formed therebetween.
  • a lens forming mixture is cured in a cavity of a desired shape formed by two or more mold parts. At least one of the mold parts is molded from a material with a differential in surface energy between a mold used to form an ophthalmic lens and the ophthalmic lens formed.
  • Embodiments can include at least one of the mold parts being transparent to polymerization initiating radiation such that a polymerizable lens forming mixture can be deposited in the cavity and the mold part and polymerizable composition can be exposed to polymerization initiating radiation.
  • Embodiments can also include methods of producing an ophthalmic lens by dispensing an uncured lens formulation onto a surface of a mold part with a surface tension less than 30 mN/m.
  • the lens can include, for example, a silicone hydrogel formulation or a hydrogel formulation.
  • Specific examples can include a lens formed from: acquafilcon A, balafilcon A, and lotrafilcon A, etafilcon A, genfilcon A, lenefilcon A, polymacon and galyfilcon A, and senofilcon A.
  • FIG. 1 illustrates a mold assembly according to some embodiments of the present invention.
  • FIG. 2 illustrates a flow chart of exemplary steps that can be executed while implementing some embodiments of the present to create a mold part.
  • FIG. 3 illustrates a flow chart of exemplary steps that can be executed while implementing some embodiments of the present to create an ophthalmic lens.
  • FIG. 4 illustrates a chart with exemplary data indicating surface energy qualities of molds fashioned from thermoplastic resins and compounds of thermoplastic resins.
  • FIG. 5 illustrates a chart with lens release time data as it relates to different mold part materials.
  • the present invention includes molds and methods for making an ophthalmic lens.
  • at least one part of a multi-part mold that is used in the manufacture of an ophthalmic lens is injection molded from a thermal plastic resin (hereinafter referred to as "TPR") compounded with an additive to reduce the surface energy of the mold material.
  • TPR thermal plastic resin
  • selection of mold part materials and monomers which result in an increased surface energy differential between monomers or cured lenses and FC molds facilitates silicone hydrogel easy lens release during aqueous hydration.
  • surface energy differential or "delta" can defined as Surface Energy of Monomer or Cured Lens - Surface Energy of Mold Part.
  • preferred embodiments include a surface energy of delta between a front curve mold part and a lens that is greater than 0.
  • the mechanisms of adhesion are generally the result of surface energy related parameters relating to the two surfaces that are in contact.
  • use of mold materials with low surface energy, such as, for example, ⁇ 30 mN/m or less, as front curve (FC) reduces adhesive force or adhesion energy between cured lens and FC mold, and, therefore, facilitate easier and faster silicone hydrogel lens release during aqueous hydration.
  • FC mold materials with lower surface energy can be successfully obtained by compounding PP with selective additives, such as Siloxane MB50-001 and Trilwet A.
  • ophthalmic lens molds comprising TPR and additive blends result in a mold surface energy of an uncoated ophthalmic lens mold of about 30 mN/m or less.
  • Methods of the present invention therefore include fashioning an ophthalmic lens from a mold with one or more mold part having an uncoated surface energy of about 30 mN/m or less.
  • One or both mold parts utilized to form an ophthalmic lens is injection molded from a TPR with an additive or other mechanism to reduce the surface energy of the mold part to less than 30mN/m.
  • Injection molding apparatus will typically include precision tooling that has been machined from a metal, such as, for example, brass, stainless steel or nickel or some combination thereof.
  • tooling is fashioned in a desired shape and machined or polished to achieve precision surface quality. The precision surface in turn increases the quality of a mold part injection molded therefrom.
  • mold parts are fashioned from a thermoplastic polyolefin with an additive to produce single use cast molds with a surface energy of less than 30 mN/m which reduces the adhesive force between a cured lens and mold parts used to fashion the lens and is therefore conducive to the manufacture of ophthalmic lenses.
  • Advantages of utilizing molds comprising a thermoplastic polyolefin material with an additive which results in a surface energy of less than 30mN/m include a diminished number of lens defects, such as holes, chips and tears resulting from demold; and also improved release from a mold part in which it is formed.
  • lens refers to any ophthalmic device that resides in or on the eye. These devices can provide optical correction or may be cosmetic.
  • the term lens can refer to a contact lens, intraocular lens, overlay lens, ocular insert, optical insert or other similar device through which vision is corrected or modified, or through which eye physiology is cosmetically enhanced (e.g. iris color) without impeding vision.
  • the term "lens forming mixture” refers to a mixture of materials that can react, or be cured, to form an ophthalmic lens. Such a mixture can include polymerizable components (monomers), additives such as UV blockers and tints, photoinitiators or catalysts, and other additives one might desire in an ophthalmic lens such as a contact or intraocular lens.
  • a preferred lens type can include a lens that is made from silicone elastomers or hydrogels, such as, for example, silicone hydrogels, fluorohydrogels, including those comprising silicone/hydrophilic macromers, silicone based monomers, initiators and additives.
  • silicone elastomers or hydrogels such as, for example, silicone hydrogels, fluorohydrogels, including those comprising silicone/hydrophilic macromers, silicone based monomers, initiators and additives.
  • some preferred lens types can also include etafilcon A, genifilcon A, lenefilcon A, polymacon, acquafilcon A, balafilcon A, lotrafilcon A, galyfilcon A, senofilcon A, silicone hydrogels.
  • a diagram of an exemplary mold for an ophthalmic lens is illustrated.
  • the terms "mold” and “mold assembly” refer to a form 100 having a cavity 105 into which a lens forming mixture can be dispensed such that upon reaction or cure of the lens forming mixture (not illustrated), an ophthalmic lens of a desired shape is produced.
  • the molds and mold assemblies 100 of this invention are made up of more than one "mold parts" or "mold pieces" 101-102.
  • the mold parts 101-102 can be brought together such that a cavity 105 is formed between the mold parts 101-102 in which a lens can be formed. This combination of mold parts 101-102 is preferably temporary. Upon formation of the lens, the mold parts 101-102 can again be separated for removal of the lens.
  • At least one mold part 101-102 has at least a portion of its surface 103-104 in contact with the lens forming mixture such that upon reaction or cure of the lens forming mixture that surface 103-104 provides a desired shape and form to the portion of the lens with which it is in contact.
  • the same is true of at least one other mold part 101-102.
  • a mold assembly 100 is formed from two parts 101-102, a female concave piece (front piece) 102 and a male convex piece (back piece) 101 with a cavity formed between them.
  • the portion of the concave surface 104 which makes contact with lens forming mixture has the curvature of the front curve of an ophthalmic lens to be produced in the mold assembly 100 and is sufficiently smooth and formed such that the surface of a ophthalmic lens formed by polymerization of the lens forming mixture which is in contact with the concave surface 104 is optically acceptable.
  • the front mold piece 102 can also have an annular flange integral with and surrounding circular circumferential edge 108 and extends from it in a plane normal to the axis and extending from the flange (not shown).
  • the back mold piece 101 has a central curved section with a concave surface 106, convex surface 103 and circular circumferential edge 107, wherein the portion of the convex surface 103 in contact with the lens forming mixture has the curvature of the back curve of a ophthalmic lens to be produced in the mold assembly 100 and is sufficiently smooth and formed such that the surface of a ophthalmic lens formed by reaction or cure of the lens forming mixture in contact with the back surface 103 is optically acceptable.
  • the inner concave surface 104 of the front mold half 102 defines the outer surface of the ophthalmic lens
  • the outer convex surface 103 of the base mold half 101 defines the inner surface of the ophthalmic lens.
  • molds 100 can include two mold parts 101-102 as described above, wherein one or both of the front curve part 102 and the back curve part 101 of the mold 100 comprises a thermoplastic polyolefin compound with a surface energy of less than 30mN/m.
  • Blended mold material resins can be obtained, for example, using different compounding methods, including hand blending, single screw compounding, twin screw and/or multiple screw compounding.
  • Preferred embodiments of a mold material include a polyolefin; cyclic olefins; and cyclic olefin copolymers; including, in some embodiments polyolefins and COCs.
  • Additives that may be compounded with the preferred mold materials include: a) Siloxanes including a class of organosilicon compounds with empirical formula R ⁇ SiO, where R is an organic group; b) non-ionic surfactants such as: alkyl ethoxylates and glycerol monostearate; and
  • Siloxanes can include [SiO(CH 3 ) 2 ] n (dimethylsiloxane) and [SiO(C6H 5 ) 2 ] n
  • Siloxane orgaosilicon compounds can include both organic and inorganic chemical compounds.
  • Organic side chains can confer hydrophobic properties and an -Si-O-Si-O- backbone is inorganic.
  • Glycerol monostearate can include a lipophilic non-ionic surfactant with HLB of 3.6 - 4.2 and a chemical formula of CH3(CH2)16COOCH2CHOHCH2OH.
  • Polyvinylpyrrolidone can include a nonionic powder with the chemical formula (C 6 H 9 NO) x
  • additives that decrease the surface energy of a mold material predominantly made up of one or more of: polyolefin; cyclic olefins; and cyclic olefin copolymers; include:
  • Glycerol Monostearate from SparTech, Inc.
  • PVP K-90 from International Specialty Products.
  • Preferred embodiments can also include a polyolefin of one or more of: polypropylene, polystyrene, polyethylene, polymethyl methacrylate, and modified polyolefins.
  • Thermoplastics that can be compounded with an additive can include, for example, one or more of: polypropylene, polystyrene and alicyclic polymers.
  • the thermoplastic resin can include an alicyclic polymer which refers to compounds having at least one saturated carbocyclic ring therein.
  • the saturated carbocyclic rings may be substituted with one or more members of the group consisting of hydrogen, Ci-ioalkyl, halogen, hydroxyl, Ci-ioalkoxycarbonyl, Ci-ioalkoxy, cyano, amido, imido, silyl, and substituted Ci_ioalkyl where the substituents are selected from one or more members of the group consisting of halogen, hydroxyl, Ci-ioalkoxycarbonyl, Ci-ioalkoxy, cyano, amido, imido, and silyl.
  • alicyclic polymers include but are not limited to polymerizable cyclobutanes, cyclopentanes, cyclohexanes, cycloheptanes, cyclooctanes, biscyclobutanes, biscyclopentanes, biscyclohexanes, biscycloheptanes, biscyclooctanes, and norbornanes. It is preferred that the at least two alicyclic polymers be polymerized by ring opening metathesis followed by hydrogenation. Since co-polymers are costly, it is preferable that the molds made from these co-polymers may be used several times to prepare lenses instead of once which is typical. For the preferred molds of the invention, they may be used more than once to produce lenses.
  • examples of alicyclic polymer containing saturated carbocyclic rings include but are not limited to the following structures
  • R . 1 - 6 are independently selected from one or more members of the group consisting of hydrogen, Ci-ioalkyl, halogen, hydroxyl, Ci-ioalkoxycarbonyl, Ci-ioalkoxy, cyano, amido, imido, silyl, and substituted Ci_ioalkyl where the substituents selected from one or more members of the group consisting of halogen, hydroxyl, Ci_ioalkoxycarbonyl, Ci_ioalkoxy, cyano, amido, imido and silyl.
  • R 1"6 may be taken together to form an unsaturated bond, a carbocyclic ring, a carbocyclic ring containing one or more unsaturated bonds, or an aromatic ring.
  • the preferred R 1"6 is selected from the group consisting of Ci-ioalkyl and substituted Ci-ioalkyl where the substituents are selected from the group consisting of halogen, hydroxyl, Ci-ioalkoxycarbonyl, Ci-ioalkoxy, cyano, amido, imido and silyl.
  • the alicyclic co-polymers consist of at least two different alicyclic polymer s.
  • the preferred alicyclic co-polymers contain two or three different alicyclic polymer s, selected from the group consisting of
  • the particularly preferred alicyclic co-polymer contains two different alicyclic momoners where the generic structure of the saturated carbocyclic rings of the alicyclic
  • polymers are of the formula R x -R 4 are Ci_ioalkyl.
  • the surface energy of the alicyclic co-polymer is between 30 and 45 dynes/cm at 25 0 C.
  • a preferred alicyclic co-polymer contains two different alicyclic polymers and is sold by Zeon Chemicals L.P. under the trade name ZEONOR. There are several different grades of ZEONOR. Various grades may have glass transition temperatures ranging from 105 0 C to 160 0 C. A specifically preferred material is ZEONOR 1060R, which according the to the manufacturer, ZEON Chemicals L.P.
  • MFR melt flow rate
  • Other mold materials that may combined with one or more additives to provide a surface energy of less then 30mN/m and used to form an ophthalmic lens mold include, for example, Zieglar-Natta polypropylene resins (sometimes referred to as znPP).
  • Zieglar-Natta polypropylene resins sometimes referred to as znPP.
  • PP 9544 MED is a clarified random copolymer for clean molding as per FDA regulation 21 CFR (c)3.2 made available by ExxonMobile Chemical Company.
  • PP 9544 MED is a random copolymer (znPP) with ethylene group (hereinafter 9544 MED).
  • Other exemplary Zieglar-Natta polypropylene resins include: Atofina Polypropylene 3761 and Atofina Polypropylene 3620 WZ.
  • the molds of the invention may contain polymers such as polypropylene, polyethylene, polystyrene, polymethyl methacrylate, modified polyolefins containing an alicyclic moiety in the main chain and cyclic polyolefins, such as, for example Zeonor and EOD 00-11 by Atofina Corporation.
  • polymers such as polypropylene, polyethylene, polystyrene, polymethyl methacrylate, modified polyolefins containing an alicyclic moiety in the main chain and cyclic polyolefins, such as, for example Zeonor and EOD 00-11 by Atofina Corporation.
  • a blend of the alicyclic co-polymers and polypropylene metalocene catalyst process with nucleation, such as ATOFINA EOD 00-11®
  • This blend can be used on either or both mold halves, where it is preferred that this blend is used on the back curve and the front curve consists of the alicyclic co-pol
  • molds 100 injection molding is utilized according to known techniques, however, embodiments can also include molds fashioned by other techniques including, for example: lathing, diamond turning, or laser cutting.
  • lenses are formed on at least one surface of both mold parts 101-102.
  • one surface of the lenses may be formed from a mold part 101-102 and the other lens surface can be formed using a lathing method, or other methods.
  • lens forming surface means a surface 103-104 that is used to mold a lens.
  • any such surface 103-104 can have an optical quality surface finish, which indicates that it is sufficiently smooth and formed so that a lens surface fashioned by the polymerization of a lens forming material in contact with the molding surface is optically acceptable.
  • the lens forming surface 103-104 can have a geometry that is necessary to impart to the lens surface the desired optical characteristics, including without limitation, spherical, aspherical and cylinder power, wave front aberration correction, corneal topography correction and the like as well as any combinations thereof.
  • a flowchart illustrates exemplary steps that may be used to implement the present invention.
  • a resin including a TPE and an additive for reducing the surface energy of the TPE is plasticized and prepared for use in an injection molding process. Injection molding techniques are well known and preparation typically involves heating resin pellets beyond a melting point.
  • the plasticized resin is injected into an injection mold shaped in a fashion suitable for creating an ophthalmic lens mold part 101-102.
  • the injection mold is typically placed in a pack and hold status for an appropriate amount of time, which can depend, for example upon the resin utilized and the shape and size of the mold part.
  • the formed mold part 101-102 is allowed to cool and at 205, the mold part 101-102 can be ejected, or otherwise removed from the injection mold.
  • some embodiments of the present invention include methods of making an ophthalmic lens comprising, consisting essentially of, or consisting of the following steps.
  • one or more mold parts 101-102 are created which comprise, consist essentially of, or consist of, including a TPR compounded with an additive for reducing the surface energy of the TPE.
  • an uncured lens formulation is dispensed onto the one or more mold parts 101-102 and at 303, the lens formulation is cured under suitable conditions. Additional steps can include, for example, hydrating a cured lens until it releases from a mold part 101-102 and leaching acute ocular discomfort agents from the lens.
  • the term "uncured” refers to the physical state of a lens formulation prior to final curing of the lens formulation to make the lens.
  • lens formulations can contain mixtures of monomers which are cured only once.
  • Other embodiments can include partially cured lens formulations that contain monomers, partially cured monomers, macromers and other components.
  • the phrase "curing under suitable conditions" refers to any suitable method of curing lens formulations, such as using light, heat, and the appropriate catalysts to produce a cured lens.
  • Light can include, in some specific examples, ultra violet light. Curing can include any exposure of the lens forming mixture to an actinic radiation sufficient to case the lens forming mixture to polymerize.
  • a graph 400 is provided which illustrates surface energy characteristics of mold materials, in including some molds fashioned from a compound including a TPR and an additive for reducing the surface energy of a mold formed from the TPE. Data associated with the chart 400 is included herein as Table 1.
  • a graph 500 illustrates how those materials with reduced mold surface energy facilitate improved release of lenses from the mold parts with the reduced surface energy, wherein the reduced surface energy resulted in a faster release time of a lens from a FC mold part.
  • a mold part material with a relatively higher surface energy such as Zeonor 1060R which has surface energy of 43.39mN/m, required a significantly longer time to release an ophthalmic lens formed therein.
  • the ophthalmic lenses formed in Zeonor 1060R mold parts required 79 seconds to release at 90 0 C and 170 seconds at 70 0 C.
  • mold parts 101-102 fashioned from a thermal plastic resin compounded with an additive to provide an increase in a delta of the surface energy of the mold part and an ophthalmic lens formed therein.

Landscapes

  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
  • Casting Or Compression Moulding Of Plastics Or The Like (AREA)
  • Eyeglasses (AREA)

Abstract

L'invention concerne des parties de moule améliorées façonnées à partir d'une résine thermoplastique mélangée avec un additif pour réduire l'énergie de surface de la partie de moule (à moins de 30 mN/m). Les parties de moule peuvent être utilisées dans des procédés de fabrication, tels que, par exemple : les procédés continus, en ligne ou discontinus de moule à lentille ophtalmique.
PCT/US2008/061004 2007-04-20 2008-04-21 Différentiel d'énergie de surface de moule à lentille ophtalmique WO2008131329A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2008242679A AU2008242679A1 (en) 2007-04-20 2008-04-21 Ophthalmic lens mold surface energy differential
BRPI0810237-6A2A BRPI0810237A2 (pt) 2007-04-20 2008-04-21 Energia de superfície diferencial de molde de lente oftálmica
EP08746429A EP2152503A1 (fr) 2007-04-20 2008-04-21 Différentiel d'énergie de surface de moule à lentille ophtalmique
CA002684870A CA2684870A1 (fr) 2007-04-20 2008-04-21 Differentiel d'energie de surface de moule a lentille ophtalmique
JP2010504307A JP2010524729A (ja) 2007-04-20 2008-04-21 眼科レンズ用鋳型表面エネルギー差

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91307807P 2007-04-20 2007-04-20
US60/913,078 2007-04-20
US11/753,198 2007-05-24
US11/753,198 US20080290534A1 (en) 2007-05-24 2007-05-24 Ophthalmic lens mold surface energy differential

Publications (1)

Publication Number Publication Date
WO2008131329A1 true WO2008131329A1 (fr) 2008-10-30

Family

ID=39671408

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/061004 WO2008131329A1 (fr) 2007-04-20 2008-04-21 Différentiel d'énergie de surface de moule à lentille ophtalmique

Country Status (10)

Country Link
EP (1) EP2152503A1 (fr)
JP (1) JP2010524729A (fr)
KR (1) KR20100017185A (fr)
AR (1) AR066116A1 (fr)
AU (1) AU2008242679A1 (fr)
BR (1) BRPI0810237A2 (fr)
CA (1) CA2684870A1 (fr)
RU (1) RU2009142845A (fr)
TW (1) TW200912424A (fr)
WO (1) WO2008131329A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009073076A1 (fr) * 2007-12-06 2009-06-11 Johnson & Johnson Vision Care, Inc. Libération de lentille ophtalmique améliorée
WO2016097152A3 (fr) * 2014-12-17 2016-11-24 Dsm Ip Assets B.V. Matière plastique pour dispositif de formage industriel
US10386653B2 (en) 2012-12-21 2019-08-20 Johnson & Johnson Vision Care, Inc. Variable optic ophthalmic device including liquid crystal elements

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104115053B (zh) * 2011-12-23 2016-04-20 庄臣及庄臣视力保护公司 包括液晶元件的可变光学眼科装置

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070490A2 (fr) * 2000-03-22 2001-09-27 Johnson & Johnson Vision Care, Inc. Moules destines a la fabrication de dispositifs ophtalmiques
EP1752281A2 (fr) * 2005-08-09 2007-02-14 CooperVision Inc. Moule pour la fabrication de lentilles de contact et systèmes et procédés pour leur fabrication

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070490A2 (fr) * 2000-03-22 2001-09-27 Johnson & Johnson Vision Care, Inc. Moules destines a la fabrication de dispositifs ophtalmiques
EP1752281A2 (fr) * 2005-08-09 2007-02-14 CooperVision Inc. Moule pour la fabrication de lentilles de contact et systèmes et procédés pour leur fabrication

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009073076A1 (fr) * 2007-12-06 2009-06-11 Johnson & Johnson Vision Care, Inc. Libération de lentille ophtalmique améliorée
US10386653B2 (en) 2012-12-21 2019-08-20 Johnson & Johnson Vision Care, Inc. Variable optic ophthalmic device including liquid crystal elements
WO2016097152A3 (fr) * 2014-12-17 2016-11-24 Dsm Ip Assets B.V. Matière plastique pour dispositif de formage industriel
EP3479985A3 (fr) * 2014-12-17 2019-06-05 DSM IP Assets B.V. Matière plastique pour formeur industriel
US11224997B2 (en) 2014-12-17 2022-01-18 Dsm Ip Assets B.V. Plastic material for industrial former

Also Published As

Publication number Publication date
JP2010524729A (ja) 2010-07-22
AR066116A1 (es) 2009-07-22
CA2684870A1 (fr) 2008-10-30
TW200912424A (en) 2009-03-16
EP2152503A1 (fr) 2010-02-17
BRPI0810237A2 (pt) 2014-10-29
RU2009142845A (ru) 2011-05-27
AU2008242679A1 (en) 2008-10-30
KR20100017185A (ko) 2010-02-16

Similar Documents

Publication Publication Date Title
EP1629960B1 (fr) Procédé et Moules pour la fabrication de lentilles ophthalmiques& xA;
US20080290534A1 (en) Ophthalmic lens mold surface energy differential
JP6010832B2 (ja) 眼科学デバイス成型用金型及び関連する方法
EP2136987A1 (fr) Moules avec élastomères thermoplastiques pour production de lentilles ophtalmiques
JP5236653B2 (ja) 眼用レンズ製造の間の余分な重合体リングの除去
EP1857246A1 (fr) Moule pour un dispositif biomédical
US20070284770A1 (en) Decreased lens delamination during ophthalmic lens manufacture
WO2008131329A1 (fr) Différentiel d'énergie de surface de moule à lentille ophtalmique
TW200824881A (en) Electrostatic charge during ophthalmic lens manufacture
CN101663158A (zh) 眼科镜片模具表面能差
US20090146329A1 (en) Lens release

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880012790.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08746429

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008242679

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 3578/KOLNP/2009

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2010504307

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2684870

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2008242679

Country of ref document: AU

Date of ref document: 20080421

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20097024210

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2009142845

Country of ref document: RU

Ref document number: 2008746429

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0810237

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20091020